Left atrial appendage occlusion.

Nietlispach, Fabian; Moarof, Igal; Taramasso, Maurizio; Maisano, Francesco; Meier, Bernhard (2017). Left atrial appendage occlusion. EuroIntervention, 13(AA), AA78-AA84. Europa Digital & Publishing 10.4244/EIJ-D-17-00412

[img] Text
AA_issue-article_10.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (450kB) | Request a copy

Left atrial appendage occlusion (LAAO) is a first-line therapy for stroke prevention in patients suffering from atrial fibrillation (AF). While patients at high risk for bleeding or patients with previous bleeding have the highest relative risk reduction from LAAO, it is the younger patients with a high lifetime bleeding risk who benefit from the highest absolute risk reduction after LAAO. Therefore, LAAO should be discussed with every AF patient, as an alternative to lifelong oral anticoagulation. The patient needs to be informed about the risks and benefits of each treatment strategy in order to take an informed treatment decision.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Meier, Bernhard

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1774-024X

Publisher:

Europa Digital & Publishing

Language:

English

Submitter:

Luana Cauto

Date Deposited:

12 Feb 2018 14:44

Last Modified:

26 Oct 2019 22:22

Publisher DOI:

10.4244/EIJ-D-17-00412

PubMed ID:

28942389

BORIS DOI:

10.7892/boris.111200

URI:

https://boris.unibe.ch/id/eprint/111200

Actions (login required)

Edit item Edit item
Provide Feedback